Skip to main content

Search

United States | en

Choose Location

Americas
Asia Pacific
Europe
International
Middle East & Africa

: Argentina | Español
: Brazil | Português
: Canada | English
: Canada | Français
: Central America | Español
: Colombia | Español
: Mexico | Español
: United States | English

: Australia | English
: Bangladesh | English
: Hong Kong S.A.R. | 繁體中文
: India | English
: Indonesia | English
: Japan | 日本語
: Korea | 한국어
: Mainland China | 中文
: Malaysia | English
: Pakistan | English
: Philippines | English
: Singapore | English
: Taiwan | 繁體中文
: Thailand | ภาษาไทย

: Austria | Deutsch
: Belgium | Français
: Belgium | Nederlands
: Bulgaria | Български
: Czech Republic | Česky
: Czech Republic | English
: Denmark | Dansk
: Estonia | Eesti
: Finland | Suomalainen
: France | Français
: Germany | Deutsch
: Greece | Ελληνικά
: Hungary | Magyar
: Ireland | English
: Italy | Italiano
: Latvia | Latvian
: Lithuania | Lithuanian
: Netherlands | Nederlands
: Norway | Norsk
: Poland | Polski
: Portugal | Português
: Romania | Română
: Russia | Русский
: Serbia | Srpski
: Slovakia | Slovensky
: Slovenia | Slovenščina
: Slovenia | English
: Spain | Español
: Sweden | Svenska
: Switzerland | Deutsch
: Switzerland | Français
: Türkiye | Türkçe
: United Kingdom | English

: Global | English
: Novartis Foundation | English

: Egypt | English
: Israel | עברית
: Saudi Arabia | العربية
: South Africa | English

us

Choose Location

Americas Asia Pacific Europe International Middle East & Africa

: Argentina | Español
: Australia | English
: Austria | Deutsch
: Bangladesh | English
: Belgium | Français
: Belgium | Nederlands
: Brazil | Português
: Bulgaria | Български
: Canada | English
: Canada | Français
: Central America | Español
: Colombia | Español
: Czech Republic | Česky
: Czech Republic | English
: Denmark | Dansk
: Egypt | English
: Estonia | Eesti
: Finland | Suomalainen
: France | Français
: Germany | Deutsch
: Greece | Ελληνικά
: Hong Kong S.A.R. | 繁體中文
: Hungary | Magyar
: India | English
: Indonesia | English
: Ireland | English
: Israel | עברית
: Italy | Italiano
: Japan | 日本語
: Korea | 한국어
: Latvia | Latvian
: Lithuania | Lithuanian
: Mainland China | 中文
: Malaysia | English
: Mexico | Español
: Netherlands | Nederlands
: Norway | Norsk
: Global | English
: Novartis Foundation | English
: Pakistan | English
: Philippines | English
: Poland | Polski
: Portugal | Português
: Romania | Română
: Russia | Русский
: Saudi Arabia | العربية
: Serbia | Srpski
: Singapore | English
: Slovakia | Slovensky
: Slovenia | Slovenščina
: Slovenia | English
: South Africa | English
: Spain | Español
: Sweden | Svenska
: Switzerland | Deutsch
: Switzerland | Français
: Taiwan | 繁體中文
: Thailand | ภาษาไทย
: Türkiye | Türkçe
: United Kingdom | English
: United States | English

About

Novartis in the US

Diversity and inclusion

Pay transparency-EPIC

Our code of ethics

Diversity and inclusion

Ensuring equity

The spirit of inclusivity

Toward a better society

Parental leave

Standing for racial equity and justice as one Novartis

Novartis US EEO / D&I report 2021

Supplier diversity

People and culture

Products

US Country Coordinating Committee

External funding

Contact us

About

Patients and caregivers

Novartis commitment to patients and caregivers

Patient assistance

Diseases

Chronic spontaneous urticaria (CSU)

Hidradenitis suppurativa (HS)

Participating in clinical trials

Patient perspectives

Adverse event reporting

The STEP program

Sickle cell disease (SCD)

Program overview

Multiple sclerosis (MS)

Cancer

Application for funding to help address health disparities

Health disparities

Novartis patient support for oncology

Patient resources

Patients and caregivers

Healthcare professionals

Novartis pipeline

Novartis clinical trials

Adverse event reporting

Novartis patient support for oncology

HCP resources

Personalized and Precision Medicine

Healthcare professionals

ESG

Ethical behavior

Code of ethics

SpeakUp

PhRMA Code on interactions with healthcare professionals

Business principles

Ethics, risk and compliance

Compliance program

State laws

Corporate integrity agreement

Payments to HCPs & HCOs

Enhanced verification request

Corporate responsibility

Population health

Novartis in society US reports

Novartis US Foundation

Environmental sustainability

People and communities

Beacon of hope

Beacon of hope: Measurable solutions for health equity

Paving the way for a brighter, more equitable future

ESG

News

News archive

Statements

Stories

Contacts

News

Careers

Career search

Meet the teams

Early career

Personal growth

How we work

Employee benefits

Diversity and inclusion

Awards & recognition

Careers

Events Listing
Home